These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Detecting transthyretin amyloid cardiomyopathy (ATTR-CM) using machine learning: an evaluation of the performance of an algorithm in a UK setting. Tsang C; Huda A; Norman M; Dickerson C; Leo V; Brownrigg J; Mamas M; Elliott P BMJ Open; 2023 Oct; 13(10):e070028. PubMed ID: 37899155 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT. Rapezzi C; Elliott P; Damy T; Nativi-Nicolau J; Berk JL; Velazquez EJ; Boman K; Gundapaneni B; Patterson TA; Schwartz JH; Sultan MB; Maurer MS JACC Heart Fail; 2021 Feb; 9(2):115-123. PubMed ID: 33309574 [TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and health care resource use of patients at risk for wild-type transthyretin amyloid cardiomyopathy identified by machine learning model. Bruno M; Sheer R; Reed C; Schepart A; Nair R; Simmons JD J Manag Care Spec Pharm; 2023 May; 29(5):530-540. PubMed ID: 37121249 [No Abstract] [Full Text] [Related]
15. Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild-type cardiac amyloidosis. Kharoubi M; Roche F; Bézard M; Hupin D; Silva S; Oghina S; Chalard C; Zaroui A; Galat A; Guendouz S; Canoui-Poitrine F; Hittinger L; Teiger E; Lefaucheur JP; Damy T ESC Heart Fail; 2021 Apr; 8(2):1656-1665. PubMed ID: 33354901 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disorders. López-Sainz Á; de Haro-Del Moral FJ; Dominguez F; Restrepo-Cordoba A; Amor-Salamanca A; Hernandez-Hernandez A; Ruiz-Guerrero L; Krsnik I; Cobo-Marcos M; Castro V; Toquero-Ramos J; Lara-Pezzi E; Fernandez-Lozano I; Alonso-Pulpon L; González-López E; Garcia-Pavia P Amyloid; 2019 Sep; 26(3):156-163. PubMed ID: 31210553 [No Abstract] [Full Text] [Related]
17. Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey. Nativi-Nicolau J; Siu A; Dispenzieri A; Maurer MS; Rapezzi C; Kristen AV; Garcia-Pavia P; LoRusso S; Waddington-Cruz M; Lairez O; Witteles R; Chapman D; Amass L; Grogan M; JACC CardioOncol; 2021 Oct; 3(4):537-546. PubMed ID: 34729526 [TBL] [Abstract][Full Text] [Related]
18. Suspicion, screening, and diagnosis of wild-type transthyretin amyloid cardiomyopathy: a systematic literature review. Bay K; Gustafsson F; Maiborg M; Bagger-Bahnsen A; Strand AM; Pilgaard T; Poulsen SH ESC Heart Fail; 2022 Jun; 9(3):1524-1541. PubMed ID: 35343098 [TBL] [Abstract][Full Text] [Related]
19. Cardiac amyloidosis-interdisciplinary approach to diagnosis and therapy. Hänselmann A; Berliner D; Bauersachs J; Bavendiek U Herz; 2022 Aug; 47(4):324-331. PubMed ID: 35674775 [TBL] [Abstract][Full Text] [Related]